These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17984734)

  • 41. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 42. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
    Clerc D; Hugli O; Trueb L; Yersin B
    Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inhibitory effects of sulfonylureas (hypoglycemic agents) on the color reaction using oxidase].
    Sakoguchi T; Kitani Y; Kimura M; Hase A; Kobayashi K; Matsuoka A
    Rinsho Byori; 1982 May; 30(5):533-7. PubMed ID: 7131818
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M; Langhan T; Prosser J; Hoffman R
    Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination of insulin and sulfonylureas: a literature review.
    Halimi S; Corticelli P; Benhamou PY
    Am J Med; 1991 Jun; 90(6A):83S-86S. PubMed ID: 1872311
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensive glucose control in type 2 diabetes.
    Tobey TA
    N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837145
    [No Abstract]   [Full Text] [Related]  

  • 49. Sustained release of a hypoglycemic sulfonylurea from silicone rubber capsules. In-vitro studies.
    Fu JC; Kale AK; Moyer DL
    Biomater Med Devices Artif Organs; 1973; 1(4):647-57. PubMed ID: 4792490
    [No Abstract]   [Full Text] [Related]  

  • 50. The benefit of increasing sulfonylurea dose.
    Epstein MD
    Ann Intern Med; 1993 Sep; 119(6):537-8. PubMed ID: 8357128
    [No Abstract]   [Full Text] [Related]  

  • 51. The benefit of increasing sulfonylurea dose.
    Feinglos MN; Hollis CR
    Ann Intern Med; 1993 Sep; 119(6):537; author reply 538. PubMed ID: 8357127
    [No Abstract]   [Full Text] [Related]  

  • 52. Sulfonylureas as second line treatment for type 2 diabetes.
    McGowan LD; Roumie CL
    BMJ; 2018 Jul; 362():k3041. PubMed ID: 30021790
    [No Abstract]   [Full Text] [Related]  

  • 53. Is There Enhanced Risk of Cerebral Ischemic Stroke by Sulfonylureas in Type 2 Diabetes?
    Parkinson FE; Hatch GM
    Diabetes; 2016 Sep; 65(9):2479-81. PubMed ID: 27555575
    [No Abstract]   [Full Text] [Related]  

  • 54. Time to be cautious about prescribing sulfonylureas?
    Dwyer M
    Br J Gen Pract; 2015 Feb; 65(631):93-4. PubMed ID: 25624301
    [No Abstract]   [Full Text] [Related]  

  • 55. The hypoglycemic sulfonylureas.
    VILLALOBOS FR
    Marquette Med Rev; 1962 Mar; 27():122-7. PubMed ID: 13925987
    [No Abstract]   [Full Text] [Related]  

  • 56. Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas.
    Trischitta V; Prudente S
    Diabetes; 2017 Aug; 66(8):2069-2071. PubMed ID: 28733308
    [No Abstract]   [Full Text] [Related]  

  • 57. Comments on "Are one or two dangerous? Sulfonylurea exposure in toddlers".
    Kreshak AA; Mariani TV; Halcomb SE; Howland MA
    J Emerg Med; 2006 May; 30(4):443; author reply 443-4. PubMed ID: 16740461
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inappropriate use of sulfonylureas in older adults].
    Pacheco J
    Rev Med Chil; 2016 Nov; 144(11):1497. PubMed ID: 28394970
    [No Abstract]   [Full Text] [Related]  

  • 59. [Reply. Inappropriate use of sulfonylureas in older adults].
    Passi Á
    Rev Med Chil; 2016 Nov; 144(11):1497-1498. PubMed ID: 28394971
    [No Abstract]   [Full Text] [Related]  

  • 60. Quantitative liquid chromatography of sulfonylureas in pharmaceutical products.
    Beyer WF
    Anal Chem; 1972 Jun; 44(7):1312-4. PubMed ID: 4658154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.